Transition Metal Chemistry
(CH2C6H4N(CH2CH3)2-4), 161.5 (NCHN); Anal. Calcd. for
C29H43N4CI: C, 72.12; H, 8.91; N, 11.60. Found C, 72.16;
H, 8.87; N, 11.62%.
(CDCI3) δ: 18.6 (p-CH3C6H4CH(CH3)2), 21.8 (p-CH3C6H
4CH(CH3)2), 30.6 (p-CH3C6H4CH(CH3)2), 23.2, 24.2, 29.6,
53.7 and 55.4 (NCH(CH2)4CHN), 67.8 and 69.7 (NCH2Ar),
70.0 (OCH2Ar), 82.9, 84.2, 85.8, 86.3, 97.5 and 108.4 (p-CH
3C6H4CH(CH3)2), 114.4, 114.8, 127.5, 127.8, 128.0, 128.5,
129.1, 131.0, 136.9 and 158.0 (CH2C6H4OCH2C6H5-4),
214.5 (Ru-Ccarb). Anal. Calc. for C45H50N2O2RuCl2: C,
65.69; H, 6.08; N, 3.41. Found: C, 65.66; H, 6.05; N, 3.43%.
Synthesis of ruthenium(II)‑NHC complexes 2
Ag2O (0.54 mmol) was added to a solution of the appropriate
perhydrobenzimidazolium chloride (1.08 mmol) in dichlo-
romethane (25 mL). The mixture was stirred for 24 h at room
temperature in the dark conditions, covered with aluminum
foil under argon and then fltered through Celite to remove
the AgCl formed. [RuCl2(p-cymene)]2 (0.43 mmol) was
added to the colorless solution, and the reaction mixture was
stirred for 24 h at room temperature. The resulting mixture
was fltered through Celite, and the solvent was removed
under vacuum to aford the product. The crude product was
recrystallized from dichloromethane/diethyl ether (1:2) at
room temperature. The orange-brown crystals were fltered
of, washed with diethyl ether (3×10 mL) and dried under
vacuum.
Dichloro‑[1,3‑bis(4‑diethylaminobenzyl)perhydrobenzimi‑
dazol‑2‑ylidene](p‑cymene)ruthenium(II) 2c Yield: 0.12 g,
75%, m.p=223–224 °C. IR, υ: 1519 cm−1 (NCN). 1H NMR
(CDCI3) δ: 0.95–1.06 (m, 4H, NCHCH2CH2CH2CH2CHN),
1.16–1.18 (m, 12H, N(CH2CH3)2), 1.19 and 1.22 (d, 6H,
J=8 Hz, p-CH3C6H4CH(CH3)2), 1.55–1.77 (m, 4H, NCH-
CH2CH2CH2CH2CHN), 2.06 (s, 3H, p-CH3C6H4CH(CH3)2),
2.80 (sept, 1H, J=8 Hz, p-CH3C6H4CH(CH3)2), 3.13–3.25
(m, 2H, NCHCH2CH2CH2CH2CHN), 3.33–3.35 (m, 8H,
N(CH2CH3)2), 4.52, 4.81, 5.40 and 5.64 (d, 4H, J=16 Hz,
p-CH3C6H4CH(CH3)2), 5.10, 5.20, 5.31 and 5.44 (d, 4H,
J = 8 Hz, NCH2Ar), 6.65, 6.70 and 7.19 (d, 8H, J = 8 Hz,
CH2C6H4N(CH2CH3)2-4). 13C NMR (CDCI3) δ: 12.6
(N(CH2CH3)2), 18.4 (p-CH3C6H4CH(CH3)2), 21.9 (p-C
H3C6H4CH(CH3)2), 30.5 (p-CH3C6H4CH(CH3)2), 23.2,
24.2, 29.2, 29.8, 53.7 and 54.8 (NCH(CH2)4CHN), 44.2
(N(CH2CH3)2), 68.2 and 68.5 (NCH2Ar), 83.4, 84.9, 85.5,
85.6, 96.7 and 107.4 (p-CH3C6H4CH(CH3)2), 111.9 124.7,
126.0, 127.3, 128.8 and 147.0 (CH2C6H4N(CH2CH3)2-4),
213.7 (Ru-Ccarb). Anal. Calc. for C39H56N4RuCI2: C, 62.23;
H, 7.45; N, 7.45. Found: C, 62.20; H, 7.43; N, 7.49%.
Dichloro‑[1,3‑bis(4‑phenylbenzyl)perhydrobenzimida‑
zol‑2‑ylidene](p‑cymene)ruthenium(II) 2a Yield: 0.13 g,
81%, m.p=257–258 °C. IR, υ: 1516 cm−1 (NCN). 1H NMR
(CDCI3) δ: 0.95–1.20 (m, 4H, NCHCH2CH2CH2CH2CHN),
1.22 and 1.29 (d, 6H, J=4 Hz, p-CH3C6H4CH(CH3)2), 1.57–
1.79 (m, 4H, NCHCH2CH2CH2CH2CHN), 2.14 (s, 3H, p-C
H3C6H4CH(CH3)2), 2.88 (sept, 1H, J=8 Hz, p-CH3C6H4C
H(CH3)2), 3.20–3.35 (m, 2H, NCHCH2CH2CH2CH2CHN),
4.64, 4.90, 5.79 and 6.00 (d, 4H, J = 16 Hz, p-CH3C6H4
CH(CH3)2), 5.10, 5.18, 5.34 and 5.49 (d, 4H, J = 8 Hz,
NCH2Ar), 7.26–7.61 (m, 18H, CH2C6H4C6H5-4). 13C NMR
(CDCI3) δ: 18.7 (p-CH3C6H4CH(CH3)2), 21.8 (p-CH3C6H
4CH(CH3)2), 30.6 (p-CH3C6H4CH(CH3)2), 23.4, 24.1, 29.7,
54.1 and 55.7 (NCH(CH2)4CHN), 68.0 and 69.8 (NCH2Ar),
83.0, 84.4, 85.9, 86.3, 97.6 and 108.4 (p-CH3C6H4CH
(CH3)2), 126.7, 126.9, 127.1, 127.3, 128.3, 128.7, 128.8,
137.5, 138.0, 140.0, 140.5 and 140.8 (CH2C6H4C6H5-4),
215.2 (Ru-Ccarb). Anal. Calc. for C43H46N2RuCl2: C, 67.71;
H, 6.04; N, 3.67. Found: C, 67.74; H, 6.06; N, 3.66%.
Dichloro‑[1,3‑bis(2,4,6‑trimethoxybenzyl)perhydrobenzimi‑
dazol‑2‑ylidene](p‑cymene)ruthenium(II) 2d Yield: 0.14 g,
83%, m.p=200–2001 °C. IR, υ: 1591 cm−1 (NCN). 1H NMR
(CDCI3) δ: 0.67–1.05 (m, 4H, NCHCH2CH2CH2CH2CHN),
1.24 and 1.28 (d, 6H, J=8 Hz, p-CH3C6H4CH(CH3)2), 1.39–
1.56 (m, 4H, NCHCH2CH2CH2CH2CHN), 2.08 (s, 3H, p-C
H3C6H4CH(CH3)2), 2.62–2.68 (m, 1H, J=8 Hz, p-CH3C6H4
CH(CH3)2), 2.78–3.09 (m, 2H, NCHCH2CH2CH2CH2CHN),
3.83 and 3.85 (s, 18H, CH2C6H2(OCH3)2-2,4,6), 4.98–5.05
(m, 4H, p-CH3C6H4CH(CH3)2), 5.65 and 5.69 (d, 4H,
J=4 Hz, NCH2Ar), 6.13 (s, 4H, CH2C6H2(OCH3)2-2,4,6).
13C NMR (CDCI3) δ: 18.8 (p-CH3C6H4CH(CH3)2), 22.3 (p-
CH3C6H4CH(CH3)2), 30.4 (p-CH3C6H4CH(CH3)2), 23.2,
24.5, 29.2, 30.2, 44.7 and 45.5 (NCH(CH2)4CHN), 55.3, 55.8
(CH2C6H2(OCH3)2-2,4,6), 65.8 and 66.3 (NCH2Ar), 83.5,
84.1, 87.9, 90.6, 92.9 and 104.8 (p-CH3C6H4CH(CH3)2),
159.8, 160.0, 160.7 and 160.8 (CH2C6H2(OCH3)2-2,4,6),
213.9 (Ru-Ccarb). Anal. Calc. for C37H50N2O6RuCl2: C,
56.20; H, 6.33; N, 3.54. Found: C, 56.24; H, 6.30; N, 3.56%.
Dichloro‑[1,3‑bis(4‑benzyloxybenzyl)perhydrobenzimida‑
zol‑2‑ylidene](p‑cymene)ruthenium(II) 2b Yield: 0.14 g,
79%, m.p=214–216 °C. IR, υ: 1511 cm−1 (NCN). 1H NMR
(CDCI3) δ: 0.90–1.19 (m, 4H, NCHCH2CH2CH2CH2CHN),
1.21 and 1.27 (d, 6H, J=8 Hz, p-CH3C6H4CH(CH3)2), 1.57–
1.75 (m, 4H, NCHCH2CH2CH2CH2CHN), 2.10 (s, 3H, p-C
H3C6H4CH(CH3)2), 2.85 (sept, 1H, J=8 Hz, p-CH3C6H4C
H(CH3)2), 3.10–3.27 (m, 2H, NCHCH2CH2CH2CH2CHN),
4.49, 4.83, 5.57 and 5.88 (d, 4H, J = 16 Hz, p-CH3C6H4
CH(CH3)2), 5.04, 5.12, 5.30 and 5.44 (d, 4H, J = 8 Hz,
NCH2Ar), 5.05 and 5.06 (s, 4H, OCH2Ar), 6.90–6.99 and
7.26–7.43 (m, 18H, CH2C6H4OCH2C6H5-4). 13C NMR
1 3